[1]刘潇聪,陈耀凯,李晖,等.复方甘草酸苷对重型肝炎的治疗作用及机制研究[J].陆军军医大学学报(原第三军医大学学报),2009,31(18):1906-1808.
　LIU Xiao-cong,CHEN Yao-kai,LI Hui,et al.Efficacy and mechanism of compound glycyrrhizin on serious hepatitis: report of 30 patients[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(18):1906-1808.
点击复制

复方甘草酸苷对重型肝炎的治疗作用及机制研究(/HTML )
分享到：

陆军军医大学学报（原第三军医大学学报）[ISSN:1000-5404/CN:51-1095/R]

卷:
31卷
期数:
2009年第18期
页码:
1906-1808
栏目:
论著
出版日期:
2009-09-30

文章信息/Info

Title:
Efficacy and mechanism of compound glycyrrhizin on serious hepatitis: report of 30 patients
作者:
刘潇聪; 陈耀凯; 李晖; 王宇明
第三军医大学西南医院全军感染病研究所;开封市第六人民医院
Author(s):
LIU Xiao-cong;  CHEN Yao-kai;  LI Hui;  WANG Yu-ming
Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University, Chongqing 400038; No. 6 People’s Hospital of Kaifeng City, Kaifeng 475000, Henan Province, China
关键词:
复方甘草酸苷; 重型肝炎; 内毒素
Keywords:
compound glycyrrhizin;  serious hepatitis;  endotoxin
分类号:
R285.6;R512.6
文献标志码:
A
摘要:
目的   观察复方甘草酸苷对于重型肝炎的治疗作用并探讨其作用机制。   方法   在综合支持疗法的基础上加用复方甘草酸苷注射液治疗重型肝炎患者30例，对照组仅采用相同的综合支持疗法，动态观察2组患者病死率、肝功能指标、血浆内毒素及多种炎性因子水平。   结果   治疗第3周末，治疗组病死率为26.7%（8/30），对照组病死率为43.3%（13/30）；治疗过程中治疗组患者血清ALT及AST水平显著低于对照组（P<0.01）；治疗第3周末，治疗组血清总胆红素水平及血浆凝血酶原时间均值显著低于对照组（P<0.05）；治疗后各时相点治疗组TNF-α水平均显著低于对照组（P<0.01）；治疗后第2、3周，治疗组患者血浆内毒素及IL-6水平显著低于对照组（P<0.01）。   结论   复方甘草酸苷用于治疗重型肝炎，可促进肝功能恢复，可能有助于降低病死率，其机制与降低患者血浆内毒素及细胞因子所致的继发性肝损伤有关。
Abstract:
Objective   To investigate the efficacy and mechanism of compound glycyrrhizin on patients with serious hepatitis.    Methods   Thirty patients who were hospitalized from August 2005 to June 2007 with diagnosed with serious hepatitis were enrolled into treatment group and treated by compound glycyrrhizin injection (80 to 100 ml per day, for 3 consecutive weeks) and common supporting medicines, while the other 30 patients in control group were treated only with same supporting medicines. Mortality, biochemical parameters, plasma levels of endotoxin and inflammatory factors in patients of both groups were observed during the treatment.    Results   By the end of three-week of treatment, 8 patients in the treatment group died with the mortality of 26.7% (8/30). Thirteen patients died in the control group and the mortality was 43.3% (13/30). Serum ALT and AST levels in treatment group were significantly lower than those of control group during the treatment. The average level of serum total bilirubin and plasma prothrombin time in treatment group was lower than those of control group by end of the third treatment week. The level of TNF-alpha in treatment group was lower than that of control group during treatment. The levels of plasma endotoxin and interleukin-6 in treatment group were significantly lower than those of the control group at the second and third treatment week.    Conclusion   Compound glycyrrhizin improves the biochemical parameters of patients with serious hepatitis, and probably, improves the survival of patients with severe hepatitis. The implying mechanism might be that compound glycyrrhizin declines plasma endotoxin levels and lessen cytokine-induced secondary hepatic injuries.

相似文献/References:

[1]何小峰,王继成,辛建兰.血浆置换治疗慢性重型肝炎60例临床分析[J].陆军军医大学学报(原第三军医大学学报),2007,29(23):2289.
　HE Xiao-feng,WANG Ji-cheng,XIN Jian-lan.Retrospective analysis of plasma exchange for chronic severe hepatitis[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(18):2289.
[2]程永波,陈志,王英杰,等.重型肝炎病人血浆对体外培养HepG2细胞生长和解毒功能的影响[J].陆军军医大学学报(原第三军医大学学报),2005,27(19):1953.
[3]赵毅,朱芳成.血浆置换治疗重型肝炎临床疗效分析[J].陆军军医大学学报(原第三军医大学学报),2009,31(15):1517.
[4]李奇芬,王宇明,彭齐荣,等.HDV 阳性重型肝炎患者外周血中 TNF、 IL-1 及 IL-6 的变化[J].陆军军医大学学报(原第三军医大学学报),1999,21(08):0.[doi:10.16016/j.1000-5404.1999.08.016 ]
　Li Qifen,Wang Yuming,Peng Qirong.[J].J Amry Med Univ (J Third Mil Med Univ),1999,21(18):0.[doi:10.16016/j.1000-5404.1999.08.016 ]
[5]李嘉佳,雷虹,毛青,等.重型肝炎合并急性血行播散性曲菌病1例[J].陆军军医大学学报(原第三军医大学学报),2003,25(02):0.[doi:10.16016/j.1000-5404.2003.02.040 ]
[6]王英杰,何念海,刘俊,等.用猪肝细胞型混合生物人工肝支持系统治疗肝衰竭的初步研究[J].陆军军医大学学报(原第三军医大学学报),2003,25(06):0.[doi:10.16016/j.1000-5404.2003.06.010 ]
　WANG Ying jie,HE Nian hai,LIU Jun,et al.[J].J Amry Med Univ (J Third Mil Med Univ),2003,25(18):0.[doi:10.16016/j.1000-5404.2003.06.010 ]
[7]李嘉佳,余小蓉.慢性重型肝炎上消化道出血的预见性护理[J].陆军军医大学学报(原第三军医大学学报),2003,25(12):0.[doi:10.16016/j.1000-5404.2003.12.033 ]
[8]吴玉章,冷泰俊,李梦东,等.慢性重型病毒性肝炎患者血清胆红素变化规律[J].陆军军医大学学报(原第三军医大学学报),1991,13(06):0.[doi:10.16016/j.1000-5404.1991.06.035 ]
[9]李奇芬,吴纯清,李平,等.重庆地区乙型病毒性肝炎患者中HDV感染状态的再探讨[J].陆军军医大学学报(原第三军医大学学报),1989,11(03):0.[doi:10.16016/j.1000-5404.1989.03.031 ]
[10]李梦东,王志新,刘思瑛,等.糖皮质激素对重型肝炎及慢性活动性肝炎的疗效[J].陆军军医大学学报(原第三军医大学学报),1985,07(02):0.[doi:10.16016/j.1000-5404.1985.02.011 ]
　Li Mengdong,et al.[J].J Amry Med Univ (J Third Mil Med Univ),1985,07(18):0.[doi:10.16016/j.1000-5404.1985.02.011 ]

更新日期/Last Update: 2009-09-16